Drug Shortage Report for JAMP-TERBINAFINE

Last updated on 2020-02-18 History
Report ID 4818
Drug Identification Number 02357070
Brand name JAMP-TERBINAFINE
Common or Proper name Terbinafine Tablets
Company Name JAMP PHARMA CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) TERBINAFINE
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code D01BA
ATC description ANTIFUNGALS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-09-15
Estimated end date 2020-12-31
Actual end date
Shortage status Actual shortage
Updated date 2020-02-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-02-18 French Compare
v10 2020-02-18 English Compare
v9 2018-12-19 French Compare
v8 2018-12-19 English Compare
v7 2018-10-15 French Compare
v6 2018-10-15 English Compare
v5 2017-09-25 French Compare
v4 2017-09-25 English Compare
v3 2017-09-25 English Compare
v2 2017-03-30 French Compare
v1 2017-03-30 English Compare

Showing 1 to 11 of 11